These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26674740)

  • 1. Development and validation of an indirect competitive ELISA for quantification of recombinant staphylokinase in rabbit plasma: Application to pharmacokinetic study.
    Kumar A; Pulicherla KK; Sambasiva Rao KR
    J Immunoassay Immunochem; 2016; 37(3):228-42. PubMed ID: 26674740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase.
    Liu J; Wang Z; He J; Wang G; Zhang R; Zhao B
    Acta Biochim Biophys Sin (Shanghai); 2014 Sep; 46(9):782-91. PubMed ID: 25098624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits.
    Li CJ; Huang J; Yang ZJ; Cao KJ
    Acta Pharmacol Sin; 2007 Jan; 28(1):58-65. PubMed ID: 17184583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of staphylokinase and alteplase in rabbit bleeding time models.
    Vanderschueren S; Collen D
    Thromb Haemost; 1996 May; 75(5):816-9. PubMed ID: 8725729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refolding of a staphylokinase variant y1-Sak by reverse dilution.
    He J; Wang G; Xu R; Feng J; Wang J; Su H; Song H
    Appl Biochem Biotechnol; 2008 Oct; 151(1):29-41. PubMed ID: 18785020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet Membrane-Coated r-SAK Improves Thrombolytic Efficacy by Targeting Thrombus.
    Hua R; Li M; Lin Q; Dong M; Gong X; Lin Z; Li Y; Li C; Wu T; Tan C; Zhang W; Wang Q; Wu T; Zhou X; Yang F; Li C
    ACS Appl Mater Interfaces; 2024 May; 16(17):21438-21449. PubMed ID: 38626407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics study of recombinant hirudin in the plasma of rats using chromogenic substrate, ELISA, and radioisotope assays.
    Jiang SY; Jiao J; Zhang TT; Xu YP
    PLoS One; 2013; 8(6):e64336. PubMed ID: 23785400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylokinase Enzyme: An Overview of Structure, Function and Engineered Forms.
    Vakili B; Nezafat N; Negahdaripour M; Yari M; Zare B; Ghasemi Y
    Curr Pharm Biotechnol; 2017; 18(13):1026-1037. PubMed ID: 29424308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis.
    Lijnen HR; Stassen JM; Vanlinthout I; Fukao H; Okada K; Matsuo O; Collen D
    Thromb Haemost; 1991 Oct; 66(4):468-73. PubMed ID: 1796398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid modification of staphylokinase and its implications on stability and activity.
    Mannully ST; Shanthi C; Pulicherla KK
    Int J Biol Macromol; 2019 Jan; 121():1037-1045. PubMed ID: 30342946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation with Eight-Arm PEG Markedly Improves the In Vitro Activity and Prolongs the Blood Circulation of Staphylokinase.
    Qi F; Hu C; Yu W; Hu T
    Bioconjug Chem; 2018 Feb; 29(2):451-458. PubMed ID: 29298046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of staphylokinase by enzyme-linked immunosorbent assay using monoclonal antibodies.
    Mike A; Ohya Y; Ohwaki M; Sakai M; Sako T; Watanabe T; Yokokura T
    Biol Pharm Bull; 1994 May; 17(5):564-7. PubMed ID: 7522729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous removal of T and B cell epitope in recombinant staphylokinase by structure-based mutagenesis of immuno-dominant Arg77 and Glu80 residues.
    Xu R; He J; Jia K; Chen X; Liu J; Zhu K
    Wei Sheng Wu Xue Bao; 2011 May; 51(5):692-703. PubMed ID: 21800633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression, purification and characterization of a novel staphylokinase with anti-platelet aggregation activity].
    Jingfang D; Jintian H; Ruiguang X; Xi C; Baohua Z
    Wei Sheng Wu Xue Bao; 2008 Sep; 48(9):1186-91. PubMed ID: 19062642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant.
    Kowalski M; Brown G; Bieniasz M; Oszajca K; Chabielska E; Pietras T; Szemraj Z; Makandjou-Ola E; Bartkowiak J; Szemraj J
    Acta Biochim Pol; 2009; 56(1):41-53. PubMed ID: 19018330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylokinase-annexin XI chimera exhibited efficient in vitro thrombolytic activities.
    Chiou JF; Woon MD; Cheng SN; Hsu CH; Cherng SC; Hsieh FK; Lin SM; Shiau CY
    Biosci Biotechnol Biochem; 2007 May; 71(5):1122-9. PubMed ID: 17485856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous elimination of T- and B-cell epitope by structure-based mutagenesis of single Glu80 residue within recombinant staphylokinase.
    He J; Xu R; Chen X; Jia K; Zhou X; Zhu K
    Acta Biochim Biophys Sin (Shanghai); 2010 Mar; 42(3):209-15. PubMed ID: 20213046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Staphylokinase for a better thrombolytic treatment of heart and platelet diseases].
    Vanderschueren S
    Verh K Acad Geneeskd Belg; 2000; 62(1):69-75. PubMed ID: 10769618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and in vivo stability and half-life of recombinant lipid modified staphylokinase.
    Mannully ST; Rekha VPB; Singh N; Shanthi C; Pulicherla KK
    Biologicals; 2020 Mar; 64():15-22. PubMed ID: 32035733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase.
    Xu Y; Shi Y; Zhou J; Yang W; Bai L; Wang S; Jin X; Niu Q; Huang A; Wang D
    Microb Cell Fact; 2017 Nov; 16(1):197. PubMed ID: 29137636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.